Corning Inc · GLW · FY2025 Q4 · Calendar Q1 2026
Corning raises growth targets as optical demand accelerates
The supplied analysis supports a constructive but conditional view: resilient optical demand, the Meta agreement and higher growth targets strengthen Corning's growth case, while capacity execution and solar-related margin pressure remain material tests.
Earnings scorecard
Reported versus consensusMarket reaction
prior-close to event-session closeAsk FN2 about GLW FY2025 Q4
Transcript, numbers and history already loadedFree account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Compared with the prior-quarter analysis, management increased its SpringBoard target from $8 billion to $11 billion of incremental annualized sales by 2028, highlighted the Meta agreement, and set 2026 capital expenditure at $1.7 billion. The emphasis shifted further toward scaling optical capacity while the solar business continues to weigh on margins.
Guidance delta
Management raised its SpringBoard target to $11 billion of incremental annualized sales by 2028, from $8 billion previously, and guided to 15% sales growth for Q1 2026.
Key takeaways
- Management reported Q4 2025 sales up 14% year over year and EPS up 26%, with operating margin at 20.2%.
- Optical communications growth is supported by GenAI demand and a multiyear agreement with Meta of up to $6 billion.
- The 2026 capital plan is $1.7 billion, focused heavily on optical capacity and the solar ramp.
- The solar business remains a profitability drag until it reaches scale.
Management priorities
- Scale optical capacity in North Carolina and Kentucky
- Invest $1.7 billion of 2026 capital expenditure, focused on optical communications
- Ramp solar manufacturing toward $2.5 billion of revenue by 2028
Follow GLW with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Sep 29, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Mizuho | Outperform | Outperform | Maintain | Sep 15, 2026 |
| Truist Securities | Buy | Hold | Upgrade | Aug 3, 2026 |
| Oppenheimer | Outperform | Outperform | Maintain | Jul 29, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Jul 29, 2026 |
| JP Morgan | Neutral | Neutral | Maintain | Jul 29, 2026 |
| Citigroup | Buy | Buy | Maintain | Jul 29, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | Jul 29, 2026 |
| B of A Securities | Buy | Buy | Maintain | Jul 6, 2026 |
| UBS | Buy | Buy | Maintain | Jun 5, 2026 |
| Susquehanna | Positive | Positive | Maintain | Apr 29, 2026 |
| Argus Research | Buy | Buy | Maintain | Oct 29, 2025 |
| HSBC | Buy | Hold | Upgrade | Jan 30, 2025 |
| Deutsche Bank | Buy | Buy | Maintain | Oct 30, 2024 |
| Fox Advisors | Overweight | Equal Weight | Upgrade | Jun 17, 2024 |
| Credit Suisse | Outperform | Outperform | Maintain | Jul 26, 2023 |
| Goldman Sachs | Buy | Neutral | Upgrade | Jan 27, 2022 |
| Cross Research | Neutral | Buy | Downgrade | Sep 17, 2019 |
| Bank of America | Buy | Neutral | Upgrade | May 1, 2019 |
| Bernstein | Market Perform | Outperform | Downgrade | Feb 1, 2017 |
| Guggenheim | Buy | Buy | Maintain | Jan 4, 2017 |
| Wells Fargo | Perform | Market Perform | Maintain | Dec 21, 2016 |
| Standpoint Research | Hold | Buy | Downgrade | Jun 13, 2016 |
| Drexel Hamilton | Sell | Buy | Downgrade | Jun 10, 2016 |
| Sterne Agee CRT | Neutral | Neutral | Maintain | Sep 28, 2015 |
| Benchmark | Hold | Hold | Maintain | Jul 29, 2015 |
| RBC Capital | Outperform | Sector Perform | Upgrade | Jun 16, 2015 |
| CLSA | Sell | Underperform | Maintain | Apr 29, 2015 |
| Jefferies | Hold | Hold | Maintain | Feb 2, 2015 |
| Standpoint | Buy | Hold | Upgrade | Oct 15, 2014 |
| Stifel Nicolaus | Buy | Buy | Maintain | Oct 23, 2013 |
| Stifel | Buy | Buy | Maintain | Oct 23, 2013 |
| Sterne Agee | Neutral | Buy | Downgrade | Oct 23, 2013 |
| PiperJaffray | Neutral | Overweight | Downgrade | Oct 11, 2013 |
| Piper Sandler | Neutral | Overweight | Downgrade | Oct 11, 2013 |
| Gilford Securities | Buy | Buy | Maintain | Sep 23, 2013 |
| Cantor Fitzgerald | Hold | Hold | Maintain | Sep 19, 2013 |
| Topeka | Buy | Buy | Maintain | Nov 27, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $157.88. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Mizuho Securities | John Roberts | $180 | $143.5 | +14.0% | Sep 15, 2026 |
| Truist Financial | Analyst unavailable | $175 | $138.25 | +10.8% | Aug 2, 2026 |
| Morgan Stanley | Analyst unavailable | $165 | $125.88 | +4.5% | Jul 29, 2026 |
| Mizuho Securities | Analyst unavailable | $210 | $125.88 | +33.0% | Jul 29, 2026 |
| UBS | Joshua Spector | $196 | $125.88 | +24.1% | Jul 29, 2026 |
| Oppenheimer | Analyst unavailable | $200 | $125.88 | +26.7% | Jul 29, 2026 |
| Barclays | Tim Long | $129 | $125.88 | -18.3% | Jul 29, 2026 |
| Oppenheimer | Martin Yang | $230 | $194.77 | +45.7% | Jul 7, 2026 |
| UBS | Analyst unavailable | $243 | $196.7 | +53.9% | Jul 6, 2026 |
| Mizuho Securities | John Roberts | $270 | $255.54 | +71.0% | Jul 1, 2026 |
| Truist Financial | Matthew Niknam | $205 | $195 | +29.8% | Jun 22, 2026 |
| UBS | Joshua Spector | $228 | $197.93 | +44.4% | Jun 5, 2026 |
| Mizuho Securities | Analyst unavailable | $220 | $207.3 | +39.4% | May 12, 2026 |
| Morgan Stanley | Meta Marshall | $180 | $192.7 | +14.0% | May 8, 2026 |
| Barclays | Tim Long | $180 | $182.42 | +14.0% | May 8, 2026 |
| UBS | Analyst unavailable | $223 | $181.57 | +41.3% | May 7, 2026 |
| Truist Financial | Analyst unavailable | $149 | $149.3 | -5.6% | Apr 29, 2026 |
| Susquehanna | Analyst unavailable | $180 | $153.05 | +14.0% | Apr 29, 2026 |
| Barclays | Tim Long | $149 | $153.05 | -5.6% | Apr 29, 2026 |
| Morgan Stanley | Meta Marshall | $140 | $164.37 | -11.3% | Apr 20, 2026 |
| Mizuho Securities | Analyst unavailable | $160 | $165.1 | +1.3% | Apr 8, 2026 |
| Morgan Stanley | Analyst unavailable | $127 | $139.51 | -19.6% | Feb 23, 2026 |
| Mizuho Securities | Analyst unavailable | $145 | $139.51 | -8.2% | Feb 23, 2026 |
| HSBC | Stephen Bersey | $135 | $131.5 | -14.5% | Feb 13, 2026 |
| UBS | Joshua Spector | $125 | $105.58 | -20.8% | Jan 30, 2026 |
| Morgan Stanley | Analyst unavailable | $103 | $100.86 | -34.8% | Jan 29, 2026 |
| Oppenheimer | Analyst unavailable | $120 | $102.76 | -24.0% | Jan 29, 2026 |
| Susquehanna | Analyst unavailable | $125 | $104.29 | -20.8% | Jan 29, 2026 |
| Mizuho Securities | Analyst unavailable | $120 | $104.29 | -24.0% | Jan 29, 2026 |
| Barclays | Analyst unavailable | $100 | $104.29 | -36.7% | Jan 29, 2026 |
| Wolfe Research | George Notter | $130 | $110.98 | -17.7% | Jan 27, 2026 |
| Morgan Stanley | Meta Marshall | $98 | $86.29 | -37.9% | Dec 17, 2025 |
| UBS | Analyst unavailable | $109 | $78.03 | -31.0% | Nov 21, 2025 |
| Argus Research | Analyst unavailable | $110 | $91.56 | -30.3% | Oct 29, 2025 |
| UBS | Analyst unavailable | $100 | $87.5 | -36.7% | Oct 29, 2025 |
| Morgan Stanley | Analyst unavailable | $82 | $87.5 | -48.1% | Oct 29, 2025 |
| Mizuho Securities | Analyst unavailable | $97 | $86.43 | -38.6% | Oct 29, 2025 |
| Oppenheimer | Analyst unavailable | $100 | $87.5 | -36.7% | Oct 29, 2025 |
| Susquehanna | Analyst unavailable | $100 | $90.01 | -36.7% | Oct 29, 2025 |
| Barclays | Analyst unavailable | $83 | $86.43 | -47.4% | Oct 29, 2025 |
| Morgan Stanley | Analyst unavailable | $75 | $87.19 | -52.5% | Oct 10, 2025 |
| Mizuho Securities | Analyst unavailable | $90 | $82.52 | -43.0% | Oct 3, 2025 |
| UBS | Joshua Spector | $91 | $79.16 | -42.4% | Sep 23, 2025 |
| UBS | Analyst unavailable | $84 | $68.47 | -46.8% | Sep 2, 2025 |
| Mizuho Securities | John Roberts | $74 | $65.77 | -53.1% | Aug 8, 2025 |
| Morgan Stanley | Analyst unavailable | $56 | $62.61 | -64.5% | Jul 30, 2025 |
| Oppenheimer | Analyst unavailable | $72 | $62.61 | -54.4% | Jul 30, 2025 |
| Susquehanna | Analyst unavailable | $75 | $62.61 | -52.5% | Jul 30, 2025 |
| Mizuho Securities | John Roberts | $59 | $53.04 | -62.6% | Jul 15, 2025 |
| Mizuho Securities | John Roberts | $52 | $42 | -67.1% | Apr 15, 2025 |
| HSBC | Stephen Bersey | $60 | $49.8 | -62.0% | Jan 30, 2025 |
| Oppenheimer | Martin Yang | $58 | $48.84 | -63.3% | Oct 30, 2024 |
| Deutsche Bank | Matt Niknam | $54 | $49.03 | -65.8% | Oct 30, 2024 |
| Barclays | Tim Long | $53 | $49.03 | -66.4% | Oct 29, 2024 |
| Bank of America Securities | Wamsi Mohan | $56 | $49.03 | -64.5% | Oct 29, 2024 |
| Deutsche Bank | Matt Niknam | $49 | $45.66 | -69.0% | Oct 9, 2024 |
| Mizuho Securities | John Roberts | $51 | $44.65 | -67.7% | Sep 24, 2024 |
| Bank of America Securities | Wamsi Mohan | $51 | $44.3 | -67.7% | Sep 20, 2024 |
| Susquehanna | Mehdi Hosseini | $55 | $44.33 | -65.2% | Sep 20, 2024 |
| Oppenheimer | Martin Yang | $51 | $44.43 | -67.7% | Sep 20, 2024 |
| Citigroup | Asiya Merchant | $50 | $41.37 | -68.3% | Sep 6, 2024 |
| Mizuho Securities | John Roberts | $47 | $40.73 | -70.2% | Aug 21, 2024 |
| Bank of America Securities | Wamsi Mohan | $46 | $39.74 | -70.9% | Jul 31, 2024 |
| Deutsche Bank | Matt Niknam | $46 | $39.74 | -70.9% | Jul 31, 2024 |
| Morgan Stanley | Meta Marshall | $39 | $42.9 | -75.3% | Jul 26, 2024 |
| Argus Research | Jim Kelleher | $50 | $43.05 | -68.3% | Jul 9, 2024 |
| Mizuho Securities | John Roberts | $42 | $38.75 | -73.4% | Jun 18, 2024 |
| US Capital Advisors | Steve Fox | $45 | $37.25 | -71.5% | Jun 17, 2024 |
| Morgan Stanley | Meta Marshall | $38 | $38.02 | -75.9% | Jun 13, 2024 |
| UBS | Joshua Spector | $38 | $35.55 | -75.9% | May 30, 2024 |
| Mizuho Securities | John Roberts | $36 | $33.44 | -77.2% | May 7, 2024 |
| Susquehanna | Analyst unavailable | $40 | $35.68 | -74.7% | Feb 2, 2023 |
| Susquehanna | Mehdi Hosseini | $50 | $42.12 | -68.3% | Jan 30, 2022 |
| Barclays | Tim Long | $52 | $40.56 | -67.1% | Jan 27, 2022 |
| Oppenheimer | Martin Yang | $48 | $34.93 | -69.6% | Oct 27, 2021 |
Track every rating change on GLW the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationCorning Incorporated operates in optical communications, display, specialty materials, automotive, and life sciences businesses in the United States, Canada, Mexico, Japan, Taiwan, China, South Korea, Germany, and internationally. The company provides optical fibers and cables; and hardware and equipment products, such as cable assemblies, fiber optic hardware and connectors, optical components and couplers, closures, network interface devices, and other accessories for the telecommunications industry, businesses, governments, and individuals. It also offers glass substrates for flat panel displays, including liquid crystal displays and organic light-emitting diodes that are used in televisions, notebook computers, desktop monitors, tablets, and handheld devices.…
Historical context
All GLW earningsTechnology peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| SNX TD Synnex Corp | FY2026 Q3 · Calendar Q3 2026 | +20.9% | -9.9% | TD SYNNEX: AI-led growth accelerates, but mix and cash flow matter |
| ADBE Adobe Inc. | FY2026 Q3 · Calendar Q3 2026 | +0.8% | +1.4% | Adobe raises FY26 outlook as AI strategy broadens |
| ORCL Oracle Corporation | FY2027 Q1 · Calendar Q3 2026 | +10.3% | -1.7% | Oracle raises FY27 outlook as AI demand accelerates cloud growth |
| SAIL SailPoint, Inc. | FY2027 Q2 · Calendar Q3 2026 | +13.8% | -1.2% | SailPoint pairs 25% ARR growth with accelerating AI-driven adoption |
| CIEN Ciena Corporation | FY2026 Q3 · Calendar Q3 2026 | +22.0% | -10.4% | Ciena raises outlook as AI networking demand lifts backlog |
| DOCU DocuSign, Inc. | FY2027 Q2 · Calendar Q3 2026 | +6.4% | +3.7% | DocuSign Q2 FY27: IAM momentum supports a raised outlook |
Latest beats and misses
Who reports nextBeat on EPS
- COSTFY2026 Q4 · September 24, 2026+3.2% EPS+2.9% move
- SNXFY2026 Q3 · September 24, 2026+20.9% EPS-9.9% move
- DRIFY2027 Q1 · September 24, 20260.0% EPS-3.0% move
- CTASFY2027 Q1 · September 23, 2026+3.0% EPS-3.4% move
- PAYXFY2027 Q1 · September 23, 2026+1.5% EPS-8.8% move
- GISFY2027 Q1 · September 23, 2026+4.6% EPS+1.0% move
Get the GLW recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
- Polygon adjusted daily market bars · 2026-09-29T16:11:01.657416+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-09-29T16:11:01.654737+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-09-29. For educational purposes only; not investment advice.